In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
In this episode, Alfred (Al) Kim, a rheumatologist from the Washington University School of Medicine in St Louis, Missouri, USA, talks about hydroxychloroquine. He discusses why the drug was initially considered promising but later shown to be ineffective, and describes the impact drug shortages have had on rheumatology practice.
Podden och tillhörande omslagsbild på den här sidan tillhör Springer Healthcare. Innehållet i podden är skapat av Springer Healthcare och inte av, eller tillsammans med, Poddtoppen.
